Clinical Trials Logo

Filter by:
NCT ID: NCT05564091 Recruiting - Clinical trials for Primary Open Angle Glaucoma

Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma

CATALYST
Start date: September 8, 2022
Phase: N/A
Study type: Interventional

A prospective, multicenter, randomized, single-masked, post-market clinical trial comparing cataract surgery in conjunction with ab-interno canaloplasty utilizing the iTrack Advance canaloplasty device (Nova Eye, Inc.) to cataract surgery only in patients with mild to moderate, primary open angle glaucoma. Subjects will be followed for 12 months.

NCT ID: NCT05563753 Recruiting - Clinical trials for Vaccination Reaction

Early Antibiotic Therapy and Vaccinations in Preterm Infants

Start date: September 1, 2022
Phase:
Study type: Observational

Since the neonatal sepsis is still one of the most common causes of death in preterm infants up to 80% receive an perinatal antibiotic treatment. It is also known that an antibiotic treatment is one of the most important influences for the establishment of the intestinal microbiome. This again is important for the development of an healthy neonatal immunosystem. A pilot study showed that an antibiotic therapy in the first week of life had a negative influence on the vaccine titers of preterm infants. In this study it will be further investigated if an early antibiotic treatment influences the development of the adaptive immunosystem in preterm infants and if this antibiotic treatment effects the development of the intestinal microbiome.

NCT ID: NCT05563376 Recruiting - Clinical trials for Univentricular Heart

Fontan-Sprechstunde

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

After successful Fontan surgery, the risk of mortality in childhood is only low. Unfortunately, some of the patients suffer from Fontan-typical long-term complications in the long-term course, whereby protein loss neuropathy must be mentioned in particular, which is described in the literature with an incidence of 3-14% (1, 2) and still has a 5-year risk of death of 6-12% today (2, 3). Protein loss tereopathy leads to loss of protein in the intestine and subsequently to diarrhea and edema. Other problems concern the liver, which can develop cirrhosis due to chronic congestion (4-6). Cardiac can lead to heart failure and arrhythmias. The registry study described in this protocol is intended to identify factors that influence the treatment outcome of patients in the Fontan circulation in the long term through systematic prospective documentation of the data from our standardized and guideline-oriented treatment.

NCT ID: NCT05563142 Recruiting - Atrial Fibrillation Clinical Trials

Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation

Style-AF
Start date: November 22, 2022
Phase: N/A
Study type: Interventional

Prospective, randomized, controlled, multi-center study to compare the safety and efficacy of the Perclose ProStyle suture-mediated closure device (PPS) as to manual compression (MC) for venous hemostasis following single shot device (SSD) based pulmonary vein isolation (PVI).

NCT ID: NCT05562128 Recruiting - Clinical trials for General Population (no Specific Condition or Disease)

Effects of Forest Therapy on Physical and Psychological Parameters in the General Population - a Randomized Controlled Trial

Start date: October 10, 2022
Phase: N/A
Study type: Interventional

In recent years, nature and forest therapy has increasingly become the focus of medical research. Recent scientific findings indicate overall positive effects of nature and forest therapy on physical and mental health. In Asia and Australia, it has already been implemented as a public health concept of prevention and health promotion. The aim of the project is to replicate the experience gained in Asia over the last three decades on the physical and psychological effects of nature/forest therapy in the context of the German forest and to investigate it further scientifically.

NCT ID: NCT05561673 Recruiting - Hepatitis B Clinical Trials

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Start date: October 4, 2022
Phase: Phase 1
Study type: Interventional

This study is conducted to assess safety and immunogenicity of GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system in healthy, HBs naïve, adults aged 18-45 years and to differentiate GSK's AS37 adjuvant system from other approved adjuvant systems and from an aluminum-based adjuvant.

NCT ID: NCT05561504 Recruiting - Gastric Cancer Clinical Trials

Helicobacter Pylori Local Prevalence and Antibiotic Resistance

HelicoPTER
Start date: March 31, 2021
Phase:
Study type: Observational

The clinical management of H. pylori infection depends essentially on two factors, prevalence and local resistance. In Germany, only limited data from rather small cohorts currently exist regarding both factors. Knowledge of the current prevalence (accounting for socioeconomic factors and age) is important for the selection of suitable detection methods, as this influences the positive and negative predictive value of the respective diagnostic methods. Current data on antibiotic resistance are essential for efficient therapy. In this clinical study, we will collect data on the frequency and severity of H. pylori infections and then, after endoscopic examination, on antibiotic resistance. Knowledge of the resistance situation is necessary for the selection of suitable therapeutic regimens. Furthermore, molecular methods for resistance detection are to be compared with conventional microbiological methods in order to be able to detect resistance more quickly. Furthermore, we aim to identify specific parameters for early detection of patients at particularly high risk of gastric cancer or with precancerous lesions due to infection. The aim is to identify carcinogenesis-relevant factors such as gastric microbiome signatures that will make it possible to identify patients who are most likely to benefit from prophylactic eradication therapy in terms of risk stratification.

NCT ID: NCT05561257 Recruiting - Neuropathic Pain Clinical Trials

Vitamin C as add-on Therapy in Patients With Acute Herpes Zoster

Start date: July 20, 2020
Phase: Phase 2
Study type: Interventional

To compare the efficacy and tolerability of three different doses of Pascorbin® besides standard medication with placebo and the reduction of herpes zoster-associated clinical symptoms as an add-on therapy for patients suffering from acute herpes zoster in primary care

NCT ID: NCT05560958 Recruiting - Cardiac Arrhythmia Clinical Trials

Post-market Clinical Follow-up Data Collection From Procedures With BIOTRONIK EP Products

BIO|COLLECT-EP
Start date: January 16, 2023
Phase:
Study type: Observational [Patient Registry]

This data collection is designed to provide evidence for the safety, performance, and clinical benefit of BIOTRONIK's EP products. Additionally, residual risks will be monitored and newly emerging risks identified.

NCT ID: NCT05560724 Recruiting - Stroke, Ischemic Clinical Trials

Network Properties as Biomarkers for Non-Invasive Brain Stimulation (NIBS) After Stroke

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

The present study will evaluate the potential of cortico-cerebellar network properties derived from neuroimaging in a group of chronic stroke patients to explain inter-subject variability in responsiveness to transcranial direct current stimulation (tDCS) targeting the cortico-spinal and cortico-cerebellar network.